Weiss Multi-Strategy Advisers’s Elevance Health ELV Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,553	Closed	-$1.63M	–	681
2023 Q1	$1.63M	Sell	3,553 -6,214	-64%	-$2.96M	0.04%	449
2022 Q4	$5.01M	Buy	+9,767	New	+$4.96M	0.14%	224
2022 Q2	–	Sell	-2,500	Closed	-$1.23M	–	695
2022 Q1	$1.23M	Buy	+2,500	New	+$1.14M	0.03%	474
2020 Q1	–	Sell	-15,000	Closed	-$4.53M	–	478
2019 Q4	$4.53M	Buy	15,000 +3,000	+25%	+$826K	0.07%	320
2019 Q3	$2.88M	Hold	12,000	–	–	0.06%	342
2019 Q2	$3.39M	Sell	12,000 -7,000	-37%	-$1.91M	0.09%	221
2019 Q1	$5.45M	Buy	19,000 +12,000	+171%	+$3.47M	0.14%	188
2018 Q4	$1.84M	Buy	+7,000	New	+$1.92M	0.08%	233

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Weiss Multi-Strategy Advisers's ELV Position: Q2 2023 in Review

Weiss Multi-Strategy Advisers sold out of Elevance Health (ELV) in Q2 2023, closing a stake of 3,553 shares — an estimated $1.63M sold.

Weiss Multi-Strategy Advisers first reported a position in ELV in Q4 2018 and held it in 8 quarters. The position peaked at $5.45M in Q1 2019. 1,523 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

Weiss Multi-Strategy Advisers reported no remaining Elevance Health position as of Q2 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 3,553 Elevance Health shares in Q2 2023, an estimated $1.63M.
Weiss Multi-Strategy Advisers first reported a position in Elevance Health in Q4 2018 and held it in 8 quarters.
Weiss Multi-Strategy Advisers's Elevance Health position peaked at $5.45M in Q1 2019.
1,523 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.